Mercy BioAnalytics Mercy BioAnalytics is a company engaged in the development of a platform for the early detection of cancer. | |||
Founding Date | Founding Date 2018 | Founding Date 2014 | Founding Date 2018 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Natick, US HQ | Locations Cambridge, US HQ | Locations Zürich, CH HQ Wien, AT |
Employees | Employees 472% increase | Employees 1910% decrease | Employees 8 |
Funding | |||
Latest funding round | Latest funding round $ 41m (about 3 years ago) | Latest funding round $ 226m (over 5 years ago) | Latest funding round $ 11.1m (almost 6 years ago) |
Total funding raised | Total funding raised $ 41m | Total funding raised $ 348.5m | Total funding raised $ 21m |

Affinivax is a vaccine development company intended to treat various infectious diseases
View company